The myeloperoxidase -463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls
- 1 November 2013
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 46 (16-17) , 1644-1648
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- An epidemic of coronary heart diseaseQJM: An International Journal of Medicine, 2012
- Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy IndividualsJACC, 2007
- Myeloperoxidase and Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Growing Significance of Myeloperoxidase in Non-infectious DiseasesClinical Chemistry and Laboratory Medicine (CCLM), 2002
- Association Between Myeloperoxidase Levels and Risk of Coronary Artery DiseaseJAMA, 2001
- Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's DiseaseExperimental Neurology, 1999
- An Allelic Association Implicates Myeloperoxidase in the Etiology of Acute Promyelocytic LeukemiaBlood, 1997
- An Alu Element in the Myeloperoxidase Promoter Contains a Composite SP1-Thyroid Hormone-Retinoic Acid Response ElementJournal of Biological Chemistry, 1996
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.Journal of Clinical Investigation, 1994
- Epidemiology of atherosclerosis: An updated overviewThe American Journal of Cardiology, 1986